港股上市公司荣昌生物（09995.HK）今日盘中大涨5.20%，引发市场关注。该公司股价走强主要受到两方面因素推动。
首先，荣昌生物近期获得上百家机构调研，投资者主要关注其核心管线开发进展。公司旗下RC18、RC48等产品在国内外的研发进展顺利，涉及多个治疗领域。此外，公司财务状况有所改善，净亏损同比缩小，这些因素增强了市场对公司未来发展的信心。
其次，今日港股生物医药板块整体表现强劲，多只个股高开。例如，康方生物（09926.HK）上涨5%，本周累计涨幅接近30%；云顶新耀-B（01952.HK）也上涨近5%。行业整体向好的氛围也为荣昌生物股价提供了支撑。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.